Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Organic & Biomolecular Chemistry|July 27, 2011
Molecular design, chemical synthesis, and biological evaluation of agents that selectively photo-degrade the transcription factor estrogen receptor-αKana Tsumura, Akane Suzuki, Takeo Tsuzuki, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Regulation of Th2 cell development by Polycomb group gene bmi-1 through the stabilization of GATA3Hiroyuki Hosokawa, Motoko Y Kimura, Ryo Shinnakasu, et al.The Journal of Experimental Medicine|April 16, 2008
Bmi1 regulates memory CD4 T cell survival via repression of the Noxa geneMasakatsu Yamashita, Makoto Kuwahara, Akane Suzuki, et al.Nature Communications|April 8, 2016
Akt1-mediated Gata3 phosphorylation controls the repression of IFNγ in memory-type Th2 cellsHiroyuki Hosokawa, Tomoaki Tanaka, Yusuke Endo, et al.The Journal of Allergy and Clinical Immunology|September 5, 2006
Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya miceYoshiyuki Tenda, Masakatsu Yamashita, Motoko Y Kimura, et al.Immunity|November 29, 2011
Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3Yusuke Endo, Chiaki Iwamura, Makoto Kuwahara, et al.Biochemical and Biophysical Research Communications|October 20, 2018
Role of leukotriene B4 12-hydroxydehydrogenase in α-galactosylceramide-pulsed dendritic cell therapy for non-small cell lung cancerKazuhisa Tanaka, Yuri Kanesaka, Mariko Takami, et al.Anticancer Research|January 9, 2021
Rapid Flow Cytometry of Gastrointestinal Stromal Tumours Closely Matches the Modified Fletcher ClassificationKiyoaki Taniguchi, Akane Suzuki, Akiko Serizawa, et al.Immunity|November 19, 2013
The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cellsDamon J Tumes, Atsushi Onodera, Akane Suzuki, et al.Cancer Immunology, Immunotherapy : CII|September 16, 2016
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cellsToshiko Kamata, Akane Suzuki, Naoko Mise, et al.Pageof 5